Cordarone
Links shared publicly online about this topic
Multaq Not as Effective as Generic Cordarone: Study
healthcentral.com — “Multaq Not as Effective as Generic Cordarone: Study” View full resource at healthcentral.com
Most Recently Shared on April 7, 2010 at 3:19 pm By:
healthcentral: Multaq Not as Effective as Generic Cordarone: Study http://bit.ly/d9kdPc Full http://bit.ly/caqqy3
Generic, Brand-Name Heart Drugs Seem to Have Same Effect on Thyroid - Drugs.com MedNews
drugs.com — “For patients taking the heart rhythm drug amiodarone (Cordarone), generic versions of the drug do not cause more incidents of thyroid dysfunction than the brand” View full resource at drugs.com
Most Recently Shared on July 13, 2011 at 5:02 pm By:
Drugs and Devices OW OW Health
Generic, Brand-Name Heart Drugs Seem to Have Same Effect on Thyroid: WEDNESDAY, July 13 -- For patients ta... http://bit.ly/nzaUWT #drug
Medical News: Novel AFib Drug Races Ahead for Rhythm Conversion - in Cardiovascular, Arrhythmias from MedPage Today
medpagetoday.com — “The novel anti-arrhythmic vernakalant wins out over amiodarone (Cordarone) for rapid restoration of sinus rhythm in new-onset atrial fibrillation, researchers affirmed in a randomized trial.” View full resource at medpagetoday.com
Most Recently Shared on January 11, 2011 at 2:48 pm By:
Novel AFib Drug Races Ahead for Rhythm Conversion (CME/CE) http://bit.ly/dMHI92
Novel AFib Drug Races Ahead for Rhythm Conversion (CME/CE) - QualityPoint Technologies
qualitypointtech.net — “(MedPage Today) -- The novel anti-arrhythmic vernakalant wins out over amiodarone (Cordarone) for rapid restoration of sinus rhythm in new-onset atrial fibrillation, researchers affirmed in a randomized trial.” View full resource at qualitypointtech.net
Most Recently Shared on January 11, 2011 at 3:01 pm By:
Novel AFib Drug Races Ahead for Rhythm Conversion (CME/CE): (MedPage Today) -- The novel anti-arrhythmic vernakala... http://bit.ly/fStjg1
ACC: Ranolazine May Prevent Post-CABG Arrhythmia (CME/CE) - QualityPoint Technologies
qualitypointtech.net — “NEW ORLEANS (MedPage Today) -- Post coronary artery bypass graft atrial fibrillation was less common in patients treated with ranolazine (Ranexa) than those treated with amiodarone (Cordarone), researchers said here.” View full resource at qualitypointtech.net
Most Recently Shared on April 6, 2011 at 10:00 pm By:
ACC: Ranolazine May Prevent Post-CABG Arrhythmia (CME/CE): NEW ORLEANS (MedPage Today) -- Post coronary artery byp... http://bit.ly/euFURo
Controversial Arrhythmia Drug Provides Only Modest Efficacy And No Clear Safety Benefits
medicalnewstoday.com — “In a rigorous new review of the antiarrhythmic drug dronedarone (Multaq), researchers at the Cedars-Sinai Heart Institute conclude that the controversial drug is only modestly effective and has no” View full resource at medicalnewstoday.com
Most Recently Shared on April 6, 2010 at 1:07 pm By:
Controversial Arrhythmia Drug Provides Only Modest Efficacy And No Clear Safety Benefits In a rigorous new review of the.. http://dld.bz/dJr
Researchers Find New Arrhythmia Drug Provides Only Modest Efficacy And No Clear Safety Benefits
medicalnewstoday.com — “In a rigorous new review of the antiarrhythmic drug dronedarone (Multaq), researchers at the Cedars-Sinai Heart Institute conclude that the controversial drug is only modestly effective and has no” View full resource at medicalnewstoday.com
Most Recently Shared on April 6, 2010 at 4:23 pm By:
MedicalNewsToday: Researchers Find New Arrhythmia Drug Provides Only Modest Efficacy And No: http://bit.ly/adSTC7 Full http://bit.ly/cXYwDQ
Medical News: ACC: Adherence to Afib Meds Poor in Real World - in Meeting Coverage, ACC from MedPage Today
medpagetoday.com — “NEW ORLEANS -- Patients diagnosed with atrial fibrillation are frequently treated with drugs such as amiodarone (Cordarone) or sotalol (Betapace), but researchers reported here that the discontinuatio” View full resource at medpagetoday.com
Most Recently Shared on April 8, 2011 at 9:40 pm By:
ACC: Adherence to Afib Meds Poor in Real World http://ht.ly/4w4dW | Most pts stop within first year.
Medical News: ACC: Adherence to Afib Meds Poor in Real World - in Meeting Coverage, ACC from MedPage Today
medpagetoday.com — “NEW ORLEANS -- Patients diagnosed with atrial fibrillation are frequently treated with drugs such as amiodarone (Cordarone) or sotalol (Betapace), but researchers reported here that the discontinuatio” View full resource at medpagetoday.com
Most Recently Shared on April 7, 2011 at 7:52 pm By:
Adherence to afib meds poor in real world #ACC2011: http://bit.ly/dKg8q5
Medical News: ACC: Ranolazine May Prevent Post-CABG Arrhythmia - in Meeting Coverage, ACC from MedPage Today
medpagetoday.com — “NEW ORLEANS -- Post coronary artery bypass graft atrial fibrillation was less common in patients treated with ranolazine (Ranexa) than those treated with amiodarone (Cordarone), researchers said here” View full resource at medpagetoday.com
Most Recently Shared on April 6, 2011 at 9:27 pm By:
ACC: Ranolazine May Prevent Post-CABG Arrhythmia (CME/CE) http://bit.ly/hJSIcZ
Medical News: ACC: Ranolazine May Prevent Post-CABG Arrhythmia - in Meeting Coverage, ACC from MedPage Today
medpagetoday.com — “NEW ORLEANS -- Post coronary artery bypass graft atrial fibrillation was less common in patients treated with ranolazine (Ranexa) than those treated with amiodarone (Cordarone), researchers said here” View full resource at medpagetoday.com
Most Recently Shared on April 6, 2011 at 9:47 pm By:
ACC: Ranolazine May Prevent Post-CABG Arrhythmia (CME/CE): NEW ORLEANS (MedPage Today… http://goo.gl/fb/CkfJy
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Heart Health
Get the latest news, information, and research on your heart. Re-tweet if you want.
-
Drugs and Devices OW
Organizing drug and medical device resources shared by health experts, advocates, and organizations into WisdomCards.
-
Medical News
unbiased curator, editor & aggregator of the latest medical and healthcare news and information
Advertisement
